☀ New York | Sunday August 16, 2026 | Sign In
⚡ TRENDING NOW

Smoking Cessation Struggles More in Developing Nations

Smoking Cessation Struggles More in Developing Nations - smoking cessation
Smoking Cessation Struggles More in Developing Nations

Quitting smoking remains a major public‑health challenge, especially in low‑ and middle‑income countries where most tobacco users live.

Limited Access to WHO‑Recommended Care

A recent study in the New England Journal of Medicine found that only 31 of the world’s lower‑and middle‑income nations meet the World Health Organization’s gold‑standard for tobacco‑cessation support under its MPOWER framework. The shortfall leaves roughly 1.3 billion people without adequate services to help them stop using tobacco.

The MPOWER strategy, defined by WHO, includes monitoring use, protecting people from smoke, offering quit assistance, warning about health risks, enforcing advertising bans, and raising taxes. While the framework is globally endorsed, implementation gaps are stark in developing regions.

Researchers from the University of York, New York University and Harvard University examined health‑system delivery in countries such as India and Vietnam. They reported that local cultural norms, government policies, funding models, and tobacco‑industry interference heavily shape the availability of cessation programs.

Related: Genetic Screening Could Reveal Early Cancer Risk in Newborns

Tailored, Low‑Cost Interventions

Co‑author Kamran Siddiqi, a public‑health professor, emphasized that health services have a duty to treat tobacco addiction and that interventions are both cost‑effective and easy to integrate. He suggested several low‑cost, high‑impact measures that could broaden support even where resources are thin.

Key recommendations include national quit‑line hotlines and mobile health applications that can deliver remote counseling at scale. Community health workers could extend guidance into rural areas, while routine screening using an “Ask‑Advise‑Connect” approach would allow doctors to identify smokers and link them directly to treatment during regular visits.

Proven cessation medications—nicotine patches, cytisine and varenicline—are also highlighted as cost‑effective tools that should be licensed worldwide. Full treatment courses need coverage by governments or insurers to remove financial barriers.

“Ensuring equitable access to full tobacco cessation support as standard care is a vital step toward preventing millions of tobacco‑related deaths globally,” said Donna Shelly, a public‑health professor at New York University.

Related: Gestational diabetes rise hits poor and ethnic minorities hardest

Such locally adapted solutions are likely to be more effective than a one‑size‑fits‑all model.

Implications for Policy and Funding

The study’s authors conclude that establishing full cessation support as a universal standard of care is essential for curbing the global burden of tobacco‑related disease. They note that full implementation of the MPOWER components would require coordinated policy action, increased funding for health‑system integration, and strong regulation to limit tobacco‑industry influence.

While the report does not provide a detailed rollout plan, it stresses the need for governments to prioritize tobacco‑cessation services alongside other health initiatives. By doing so, nations can address a leading cause of preventable mortality and achieve broader economic benefits linked to improved public health.

Leave a Reply

Your email address will not be published. Required fields are marked *